Skip to main content
SpringerLink
Log in

Percutane behandeling van coronaire atherotrombose

  • Chapter
Book cover Leerboek atherotrombose

  • 303 Accesses

Abstract

De percutane behandeling van coronaire atherotrombose is de laatste kwart eeuw uitgegroeid tot de meest toegepaste therapeutische benadering bij patiënten met coronaire hartziekten bij wie medicamenteuze therapie alleen niet afdoende is. Per jaar ondergaan ongeveer 1,8 per 1000 Nederlanders een dergelijke behandeling.1–3 De ontwikkelingen die dit mogelijk hebben gemaakt, vinden hun oorsprong in de eerste helft van de vorige eeuw. Nadat Claude Bernard in 1844 de eerste hartkatheterisatie uitvoerde bij een paard, werd in 1929 de eerste gedocumenteerde hartkatheterisatie verricht bij de mens. Op 25-jarige leeftijd schoof Werner Forssmann een katheter, die voordien uitsluitend gebruikt werd voor een urologische toepassing, door een eigen armvene naar het hart en legde dat op een röntgenfoto vast.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatuur

  1. Van der Wall EE, et al., redactie. Cardiologie. Houten: Bohn Stafleu van Loghum, 2008. Tweede herziene druk. ISBN 9789031348299.

    Google Scholar 

  2. Baim DS, Grossman W. Grossman’s Cardiac catheterization, angiography, and intervention, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.

    Google Scholar 

  3. Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996;335:1290–302.

    Article  PubMed  CAS  Google Scholar 

  4. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronaryartery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61–8.

    Article  PubMed  CAS  Google Scholar 

  5. Serruys PW, Jaegere P de, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489–95.

    Article  PubMed  CAS  Google Scholar 

  6. Al Suwaidi J, Berger PB, Holmes DR Jr. Coronary artery stents. JAMA 2000;284: 1828–36.

    Article  PubMed  CAS  Google Scholar 

  7. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361: 247–9.

    Article  PubMed  Google Scholar 

  8. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. RAVEL Study Group. Randomized study with the sirolimus-coated Bx velocity balloonexpandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773–80.

    Article  PubMed  CAS  Google Scholar 

  9. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527–33.

    Article  PubMed  CAS  Google Scholar 

  10. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344:1117–24.

    Article  PubMed  CAS  Google Scholar 

  11. Legrand VM, Serruys PW, Unger F, Hout BA van, Vrolix MC, Fransen GM, et al. Arterial Revascularization Therapy Study (ARTS) Investigators. Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation 2004;109:1114–20.

    Article  PubMed  Google Scholar 

  12. O’Neill WW, Grines CL. Surgery or stent? The gap continues to narrow. Lancet 2002;360:961–2.

    Article  PubMed  Google Scholar 

  13. Hemingway H, Crook AM, Feder G, Banerjee S, Dawson JR, Magee P, et al. Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med 2001;344:645–54.

    Article  PubMed  CAS  Google Scholar 

  14. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman BR, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators. J Am Coll Cardiol 1995;26:594–605.

    Article  PubMed  CAS  Google Scholar 

  15. Pepine CJ, Sharaf B, Andrews TC, Forman S, Geller N, Knatterud G, et al. Relation between clinical, angiographic and ischemic findings at baseline and ischemia- related adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP Study Group. J Am Coll Cardiol 1997;29:1483–9.

    Article  PubMed  CAS  Google Scholar 

  16. Bhatt DL, Topol EJ. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. JAMA 2000;284:1549–58.

    Article  PubMed  CAS  Google Scholar 

  17. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879–87.

    Article  PubMed  CAS  Google Scholar 

  18. Zijlstra F, Hoorntje JC, Boer MJ de, Reiffers S, Miedema K, Ottervanger JP, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413–9.

    Article  PubMed  CAS  Google Scholar 

  19. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13–20.

    Article  PubMed  Google Scholar 

  20. Lange HW, von Boetticher. Randomized comparison of operator radiation exposure during coronary angiography and intervention by radial or femoral approach. Catheter Cardiovasc Interv 2006;67:12–6.

    Article  PubMed  Google Scholar 

  21. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR et al. Drug-eluting stents vs. Coronary-artery bypass grafting in multivessel coronary artery disease. N Engl J Med 2008;358:331–41.

    Article  PubMed  CAS  Google Scholar 

  22. Agostoni P, Biondi-Zoccai GGL, De Benedictis ML, Rigattieri S, Turri M, Anselmi M et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures. J Am Coll Cardiol 2004;44:349–56.

    Article  PubMed  Google Scholar 

  23. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GFH, de Smet BJGL, van den Heuvel AFM et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557–67.

    Article  PubMed  CAS  Google Scholar 

  24. Marroquin OC, Selzer F, Mulukutla SR, Williams DO, Vlachos HA, Wilensky RL et al. A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 2008;358:342–52.

    Article  PubMed  CAS  Google Scholar 

  25. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 2007;357:1393–402.

    Article  PubMed  CAS  Google Scholar 

  26. Task force members: Silber S, Albertsson P, Avles FF, Camici PG, Colombo A, Hamm C et al. Guidelines for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804–47.

    Article  PubMed  Google Scholar 

  27. Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE et al. Offsetting impact of thrombosis and restenosis on the occurence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 2007;115(22):2842–7.

    Article  PubMed  Google Scholar 

  28. Working group of interventional cardiology. Dutch guidelines for interventional cardiology 2004. Institutional and operator competence and requirements for training. www.nvvc.nl.

  29. Deuling JH, Vermeulen RP, Anthonio RA, van den Heuvel AF, Jaarsma T, Jessurun GA et al. Closure of the femoral artery after cardiac catheterization: A comparison of Angio-seal, StarClose, and manual compression. Catheter Cardiovasc Interven 2008;71(4):518–23.

    Article  CAS  Google Scholar 

  30. Bravata DM, Gienger AL, McDonals KM, Sundaram V, Perez MV, Varghese R et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med 2007;147(10):703–16.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitair Medisch Centrum, Groninge, Netherlands

    Dr. G. A. J. Jessurun (Cardioloog) & Prof.dr. F. Zijlstra (Cardioloog)

Authors
  1. Dr. G. A. J. Jessurun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof.dr. F. Zijlstra
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Eerste druk

About this chapter

Cite this chapter

Jessurun, G.A.J., Zijlstra, F. (2008). Percutane behandeling van coronaire atherotrombose. In: Leerboek atherotrombose. Bohn Stafleu van Loghum, Houten. https://doi.org/10.1007/978-90-313-6597-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-90-313-6597-5_7

  • Publisher Name: Bohn Stafleu van Loghum, Houten

  • Print ISBN: 978-90-313-5229-6

  • Online ISBN: 978-90-313-6597-5

  • eBook Packages: Dutch language eBook collection

Publish with us

Policies and ethics

Search

Navigation